These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10441850)

  • 1. [Neurasthenia as a variant of the asthenic syndrome: a pharmacotherapeutic analysis modelled on tanakan therapy].
    Krasnov VN; Vel'tishev DIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(7):37-40. PubMed ID: 10441850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of asthenic disorders with tanakan].
    Milopol'skaia IM
    Ter Arkh; 2001; 73(10):45-7. PubMed ID: 11763515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tanakan on psychophysiological status of patients with asthenic disorders].
    Neznamov GG; Teleshova ES; Siuniakov SA; Morozov IS; Davydova IA; Zhirnov EN
    Eksp Klin Farmakol; 2002; 65(1):19-23. PubMed ID: 12025777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthenic disorders in children and their differentiated treatment].
    Chutko LS; Surushkina SI; Nikishena IS; Iakovenko EA; Anisimova TI; Bondarchuk IL; Sergeev AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):99-103. PubMed ID: 25726788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Asthenic disorders in children].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Anisimova TI; Kuzovenkova MP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):26-9. PubMed ID: 21183919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinico-psychological analysis of the characteristics of patients with an asthenic syndrome of a psychogenic and somatogenic nature].
    Kulikovskiĭ VV; Ermolaev AI; Zhukov KN; Shatikhin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):73-6. PubMed ID: 8009940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of neurasthenia with combined western and traditional Chinese medicine by basing therapy on type differentiation of the disease].
    Zhou K
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Oct; 19(5):306-8. PubMed ID: 3582017
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH].
    Fedin AI; Solov'eva ÉI; Mironova OP; Fedotova AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):104-111. PubMed ID: 25726789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Torpid schizophrenia with a predominance of asthenic disorders].
    Gorchakova LN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):76-82. PubMed ID: 2901179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A symbol of life force: Ginkgo biloba L].
    Simányi M; Swoboda H; Kopp B
    Wien Med Wochenschr; 1999; 149(8-10):229-30. PubMed ID: 10483687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of special Ginkgo biloba extract for cognitive disorders in the elderly].
    Simányi M
    Wien Med Wochenschr; 1999; 149(8-10):231-4. PubMed ID: 10483688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asthenic states and one of their modern treatments].
    Bugard P
    Therapeutique; 1972 Apr; 48(4):297-302. PubMed ID: 5073101
    [No Abstract]   [Full Text] [Related]  

  • 13. [The results of using different forms of a Ginkgo biloba extract (EGb 761) in the combined treatment of patients with circulatory encephalopathy].
    Ivaniv OP
    Lik Sprava; 1998 Dec; (8):123-8. PubMed ID: 10204370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of tanakan on blood lipid peroxidation and platelet aggregation properties in patients with insulin-dependent diabetes mellitus].
    Balashova TS; Kubatiev AA
    Ter Arkh; 1998; 70(12):49-54. PubMed ID: 10067254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cognitive, subjective, and physical effects of a ginkgo biloba/panax ginseng combination in healthy volunteers with neurasthenic complaints.
    Wesnes KA; Faleni RA; Hefting NR; Hoogsteen G; Houben JJ; Jenkins E; Jonkman JH; Leonard J; Petrini O; van Lier JJ
    Psychopharmacol Bull; 1997; 33(4):677-83. PubMed ID: 9493479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder].
    Polunina AG; Osinovskaia NA; Gudkova AN; Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):28-33. PubMed ID: 24662341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. A randomised, double-blind, multicentric clinical trial.
    Schweizer J; Hautmann C
    Arzneimittelforschung; 1999 Nov; 49(11):900-4. PubMed ID: 10604042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification of asthenic conditions (reactions, phases) in psychopathy].
    Sokolovskaia LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(11):110-4. PubMed ID: 2624037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)].
    Neznamov GG; Siuniakov SA; Teleshova SE; Chumakov DV; Reutova MA; Siuniakov TS; Mametova LE; Dorofeeva OA; Grishin SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):20-6. PubMed ID: 19491814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000].
    Clostre F
    Ann Pharm Fr; 1999 Jul; 57 Suppl 1():1S8-88. PubMed ID: 10481350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.